All bariatric surgeries are not created equal: insights from mechanistic comparisons
GLP-1 receptor agonists (GLP-1 RAs) are newer medications that were initially released as treatment for diabetes In higher doses, they have shown promising results in weight loss also Wegovy (semaglutide) was the first GLP-1 RA approved for weight loss by the FDA Zepbound (tirzepatide) was just recently approved by the FDA Early data shows better weight loss with Zepbound/tirzepatide than Wegovy/semaglutide What are GLP-1 receptor agonists and why do they work
GLP-1 receptor agonists may offer benefits in managing non-alcoholic fatty liver disease by reducing liver fat content and improving liver enzymes
GLP-1 Reduces appetite, slows gastric emptying GIP Enhances insulin, improves fat metabolism Glucagon Increases energy expenditure, burns fat Based on Phase 2 clinical trial data (published in NEJM, 2023), retatrutide's side effects are primarily gastrointestinal, similar to other GLP-1 agonists but with some differences due to the glucagon component
full vestibular compensation and symptom resolution may take 23 months
Take Charge of Your Mental Health Today Why settle for brain fog, stress, or anxiety when you can feel clear-headed, focused, and emotionally balanced
